Daxor Corporation (DXR)
USD 8.0
(2.56%)
USD 8.0
(2.56%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 858.75 Thousand USD | -33.51% |
| 2022 | 1.29 Million USD | -66.27% |
| 2021 | 3.82 Million USD | 336.26% |
| 2020 | 877.68 Thousand USD | -38.85% |
| 2019 | 1.43 Million USD | -68.55% |
| 2018 | 4.56 Million USD | -17.81% |
| 2017 | 5.55 Million USD | 5.18% |
| 2016 | 5.28 Million USD | -18.34% |
| 2015 | 6.46 Million USD | -69.88% |
| 2014 | 21.46 Million USD | 2.1% |
| 2013 | 21.02 Million USD | -0.91% |
| 2012 | 21.21 Million USD | -57.15% |
| 2011 | 49.5 Million USD | 12.01% |
| 2010 | 44.2 Million USD | 60.37% |
| 2009 | 27.56 Million USD | -17.39% |
| 2008 | 33.36 Million USD | -29.97% |
| 2007 | 47.64 Million USD | 46.47% |
| 2006 | 32.52 Million USD | 56.23% |
| 2005 | 20.82 Million USD | 29.74% |
| 2004 | 16.04 Million USD | 35.05% |
| 2003 | 11.88 Million USD | 48.05% |
| 2002 | 8.02 Million USD | -2.25% |
| 2001 | 8.21 Million USD | -24.69% |
| 2000 | 10.9 Million USD | 66.04% |
| 1999 | 6.56 Million USD | -25.38% |
| 1998 | 8.8 Million USD | 4.76% |
| 1997 | 8.4 Million USD | 52.73% |
| 1996 | 5.5 Million USD | -1.79% |
| 1995 | 5.6 Million USD | 43.59% |
| 1994 | 3.9 Million USD | -17.02% |
| 1993 | 4.7 Million USD | -54.37% |
| 1992 | 10.3 Million USD | 1.98% |
| 1991 | 10.1 Million USD | -9.01% |
| 1990 | 11.1 Million USD | 42.31% |
| 1989 | 7.8 Million USD | -30.97% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.72 Million USD | 0.0% |
| 2024 Q1 | 1.72 Million USD | 100.32% |
| 2023 Q3 | 858.75 Thousand USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | 858.75 Thousand USD | 0.0% |
| 2023 FY | 858.75 Thousand USD | -33.51% |
| 2022 FY | 1.29 Million USD | -66.27% |
| 2022 Q2 | 2.81 Million USD | 0.0% |
| 2022 Q4 | 1.29 Million USD | 0.0% |
| 2022 Q3 | 1.29 Million USD | -54.11% |
| 2022 Q1 | 2.81 Million USD | -26.49% |
| 2021 Q1 | 2.15 Million USD | 146.07% |
| 2021 FY | 3.82 Million USD | 336.26% |
| 2021 Q2 | 2.15 Million USD | 0.0% |
| 2021 Q3 | 3.82 Million USD | 77.29% |
| 2021 Q4 | 3.82 Million USD | 0.0% |
| 2020 Q3 | 877.68 Thousand USD | -77.21% |
| 2020 FY | 877.68 Thousand USD | -38.85% |
| 2020 Q4 | 877.68 Thousand USD | 0.0% |
| 2020 Q1 | 3.85 Million USD | 168.35% |
| 2020 Q2 | 3.85 Million USD | 0.0% |
| 2019 Q3 | 1.43 Million USD | -67.36% |
| 2019 FY | 1.43 Million USD | -68.55% |
| 2019 Q1 | 4.39 Million USD | -3.65% |
| 2019 Q2 | 4.39 Million USD | 0.0% |
| 2019 Q4 | 1.43 Million USD | 0.0% |
| 2018 Q1 | 4.45 Million USD | -19.83% |
| 2018 FY | 4.56 Million USD | -17.81% |
| 2018 Q4 | 4.56 Million USD | 0.0% |
| 2018 Q3 | 4.56 Million USD | 2.52% |
| 2018 Q2 | 4.45 Million USD | 0.0% |
| 2017 Q1 | 6.05 Million USD | 14.74% |
| 2017 Q2 | 6.05 Million USD | 0.0% |
| 2017 Q3 | 5.55 Million USD | -8.34% |
| 2017 Q4 | 5.55 Million USD | 0.0% |
| 2017 FY | 5.55 Million USD | 5.18% |
| 2016 Q3 | 5.28 Million USD | 8.01% |
| 2016 Q4 | 5.28 Million USD | 0.0% |
| 2016 Q1 | 4.88 Million USD | -24.39% |
| 2016 Q2 | 4.88 Million USD | 0.0% |
| 2016 FY | 5.28 Million USD | -18.34% |
| 2015 Q3 | 6.46 Million USD | -44.28% |
| 2015 Q2 | 11.6 Million USD | 0.0% |
| 2015 Q1 | 11.6 Million USD | -45.94% |
| 2015 Q4 | 6.46 Million USD | 0.0% |
| 2015 FY | 6.46 Million USD | -69.88% |
| 2014 Q1 | 19.63 Million USD | -6.61% |
| 2014 Q2 | 19.63 Million USD | 0.0% |
| 2014 FY | 21.46 Million USD | 2.1% |
| 2014 Q3 | 21.46 Million USD | 9.32% |
| 2014 Q4 | 21.46 Million USD | 0.0% |
| 2013 Q3 | 21.02 Million USD | -2.66% |
| 2013 Q2 | 21.59 Million USD | 0.0% |
| 2013 FY | 21.02 Million USD | -0.91% |
| 2013 Q1 | 21.59 Million USD | 1.8% |
| 2013 Q4 | 21.02 Million USD | 0.0% |
| 2012 FY | 21.21 Million USD | -57.15% |
| 2012 Q4 | 21.21 Million USD | 0.0% |
| 2012 Q3 | 21.21 Million USD | 0.0% |
| 2011 Q3 | 50.63 Million USD | -0.05% |
| 2011 FY | 49.5 Million USD | 12.01% |
| 2011 Q4 | 49.5 Million USD | -2.22% |
| 2011 Q1 | 46.56 Million USD | 5.36% |
| 2011 Q2 | 50.65 Million USD | 8.77% |
| 2010 FY | 44.2 Million USD | 60.37% |
| 2010 Q3 | 37.93 Million USD | 2.08% |
| 2010 Q2 | 37.16 Million USD | -7.93% |
| 2010 Q1 | 40.36 Million USD | 46.44% |
| 2010 Q4 | 44.2 Million USD | 16.52% |
| 2009 Q2 | 29.81 Million USD | -1.73% |
| 2009 FY | 27.56 Million USD | -17.39% |
| 2009 Q1 | 30.33 Million USD | -9.07% |
| 2009 Q3 | 29.3 Million USD | -1.69% |
| 2009 Q4 | 27.56 Million USD | -5.96% |
| 2008 FY | 33.36 Million USD | -29.97% |
| 2008 Q4 | 33.36 Million USD | -12.51% |
| 2008 Q3 | 38.13 Million USD | -15.74% |
| 2008 Q2 | 45.25 Million USD | 66.69% |
| 2008 Q1 | 27.15 Million USD | -43.01% |
| 2007 Q2 | 28.08 Million USD | -12.58% |
| 2007 Q3 | 30.9 Million USD | 10.03% |
| 2007 Q4 | 47.64 Million USD | 54.17% |
| 2007 FY | 47.64 Million USD | 46.47% |
| 2007 Q1 | 32.12 Million USD | -1.24% |
| 2006 FY | 32.52 Million USD | 56.23% |
| 2006 Q2 | 20.6 Million USD | 5.1% |
| 2006 Q1 | 19.6 Million USD | -5.83% |
| 2006 Q3 | 25.1 Million USD | 21.85% |
| 2006 Q4 | 32.52 Million USD | 29.55% |
| 2005 Q4 | 20.82 Million USD | -4.65% |
| 2005 Q2 | 20.79 Million USD | 26.91% |
| 2005 Q1 | 16.38 Million USD | 2.12% |
| 2005 FY | 20.82 Million USD | 29.74% |
| 2005 Q3 | 21.83 Million USD | 4.99% |
| 2004 Q4 | 16.04 Million USD | 10.04% |
| 2004 Q3 | 14.58 Million USD | 8.32% |
| 2004 FY | 16.04 Million USD | 35.05% |
| 2004 Q1 | 12.59 Million USD | 5.98% |
| 2004 Q2 | 13.46 Million USD | 6.91% |
| 2003 Q2 | 10.49 Million USD | 35.49% |
| 2003 FY | 11.88 Million USD | 48.05% |
| 2003 Q4 | 11.88 Million USD | 11.73% |
| 2003 Q3 | 10.63 Million USD | 1.37% |
| 2003 Q1 | 7.74 Million USD | -3.53% |
| 2002 Q2 | 8.03 Million USD | -10.9% |
| 2002 Q1 | 9.01 Million USD | 9.76% |
| 2002 Q3 | 6.39 Million USD | -20.4% |
| 2002 Q4 | 8.02 Million USD | 25.57% |
| 2002 FY | 8.02 Million USD | -2.25% |
| 2001 Q3 | 8.77 Million USD | -16.78% |
| 2001 Q2 | 10.53 Million USD | 2.27% |
| 2001 Q1 | 10.3 Million USD | -5.49% |
| 2001 FY | 8.21 Million USD | -24.69% |
| 2001 Q4 | 8.21 Million USD | -6.38% |
| 2000 Q3 | 9.76 Million USD | 31.07% |
| 2000 Q2 | 7.45 Million USD | 11.2% |
| 2000 Q1 | 6.7 Million USD | 2.04% |
| 2000 FY | 10.9 Million USD | 66.04% |
| 2000 Q4 | 10.9 Million USD | 11.64% |
| 1999 Q2 | 7.9 Million USD | 21.54% |
| 1999 FY | 6.56 Million USD | -25.38% |
| 1999 Q3 | 7.2 Million USD | -8.86% |
| 1999 Q4 | 6.56 Million USD | -8.8% |
| 1999 Q1 | 6.5 Million USD | -26.14% |
| 1998 Q3 | 8.1 Million USD | 10.96% |
| 1998 Q2 | 7.3 Million USD | -8.75% |
| 1998 FY | 8.8 Million USD | 4.76% |
| 1998 Q1 | 8 Million USD | -4.76% |
| 1998 Q4 | 8.8 Million USD | 8.64% |
| 1997 Q3 | 6.4 Million USD | -7.25% |
| 1997 Q2 | 6.9 Million USD | 56.82% |
| 1997 Q1 | 4.4 Million USD | -20.0% |
| 1997 FY | 8.4 Million USD | 52.73% |
| 1997 Q4 | 8.4 Million USD | 31.25% |
| 1996 Q2 | 4.5 Million USD | 4.65% |
| 1996 Q4 | 5.5 Million USD | 14.58% |
| 1996 Q3 | 4.8 Million USD | 6.67% |
| 1996 Q1 | 4.3 Million USD | -23.21% |
| 1996 FY | 5.5 Million USD | -1.79% |
| 1995 Q1 | 2.7 Million USD | -30.77% |
| 1995 FY | 5.6 Million USD | 43.59% |
| 1995 Q4 | 5.6 Million USD | -16.42% |
| 1995 Q3 | 6.7 Million USD | 24.07% |
| 1995 Q2 | 5.4 Million USD | 100.0% |
| 1994 FY | 3.9 Million USD | -17.02% |
| 1994 Q3 | 2.7 Million USD | -43.75% |
| 1994 Q1 | 6.9 Million USD | 46.81% |
| 1994 Q2 | 4.8 Million USD | -30.43% |
| 1994 Q4 | 3.9 Million USD | 44.44% |
| 1993 Q4 | 4.7 Million USD | -26.56% |
| 1993 Q3 | 6.4 Million USD | -15.79% |
| 1993 FY | 4.7 Million USD | -54.37% |
| 1993 Q1 | 8.8 Million USD | -14.56% |
| 1993 Q2 | 7.6 Million USD | -13.64% |
| 1992 Q4 | 10.3 Million USD | 24.1% |
| 1992 Q3 | 8.3 Million USD | 1975.0% |
| 1992 FY | 10.3 Million USD | 1.98% |
| 1992 Q1 | 12.4 Million USD | 22.77% |
| 1992 Q2 | 400 Thousand USD | -96.77% |
| 1991 Q3 | 9.5 Million USD | 0.0% |
| 1991 Q4 | 10.1 Million USD | 6.32% |
| 1991 Q1 | 10.9 Million USD | -1.8% |
| 1991 FY | 10.1 Million USD | -9.01% |
| 1990 Q2 | 7.9 Million USD | 5.33% |
| 1990 Q3 | 6.9 Million USD | -12.66% |
| 1990 Q4 | 11.1 Million USD | 60.87% |
| 1990 Q1 | 7.5 Million USD | -3.85% |
| 1990 FY | 11.1 Million USD | 42.31% |
| 1989 FY | 7.8 Million USD | -30.97% |
| 1989 Q4 | 7.8 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 99.322% |
| AngioDynamics, Inc. | 112.08 Million USD | 99.234% |
| AtriCure, Inc. | 147.76 Million USD | 99.419% |
| Avinger, Inc. | 19.97 Million USD | 95.7% |
| Azenta, Inc. | 351.22 Million USD | 99.755% |
| BioLife Solutions, Inc. | 75.05 Million USD | 98.856% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 99.979% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | 94.735% |
| Femasys Inc. | 9.4 Million USD | 90.867% |
| GlucoTrack, Inc. | 1.7 Million USD | 49.721% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 98.664% |
| Hologic, Inc. | 4.02 Billion USD | 99.979% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.962% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 99.958% |
| KORU Medical Systems, Inc. | 8.1 Million USD | 89.407% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | 98.243% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -30.127% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -30.127% |
| Masimo Corporation | 1.67 Billion USD | 99.949% |
| Microbot Medical Inc. | 3.82 Million USD | 77.555% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | 96.576% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 99.924% |
| Nephros, Inc. | 3.5 Million USD | 75.485% |
| NovoCure Limited | 783.63 Million USD | 99.89% |
| NEXGEL, Inc. | 4.78 Million USD | 82.068% |
| NEXGEL, Inc. | 4.78 Million USD | 82.068% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 99.007% |
| OraSure Technologies, Inc. | 52.17 Million USD | 98.354% |
| Pro-Dex, Inc. | 23.34 Million USD | 96.321% |
| Pulse Biosciences, Inc. | 16.44 Million USD | 94.778% |
| Predictive Oncology Inc. | 6.14 Million USD | 86.026% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | 87.454% |
| QuidelOrtho Corporation | 3.55 Billion USD | 99.976% |
| Repligen Corporation | 853.2 Million USD | 99.899% |
| Sanara MedTech Inc. | 29.28 Million USD | 97.067% |
| STAAR Surgical Company | 102.73 Million USD | 99.164% |
| Sharps Technology, Inc. | 3.85 Million USD | 77.723% |
| Utah Medical Products, Inc. | 7.14 Million USD | 87.981% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 99.979% |
| Jin Medical International Ltd. | 8.92 Million USD | 90.377% |